Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells
2008

EGCG and Its Effect on Tumor Cell Migration

publication Evidence: moderate

Author Information

Author(s): Hazgui Salma, Bonnomet Arnaud, Nawrocki-Raby Béatrice, Milliot Magali, Terryn Christine, Cutrona Jérôme, Polette Myriam, Birembaut Philippe, Zahm Jean-Marie

Primary Institution: INSERM, UMRS903, Reims, France

Hypothesis

The study investigates the effect of EGCG on the migratory behavior of tumor bronchial epithelial cells.

Conclusion

EGCG inhibits the migration of bronchial tumor cells and could be a potential treatment for tumor invasion.

Supporting Evidence

  • EGCG significantly decreased the migration speed of BZR cells in both 2D and 3D models.
  • The study found that EGCG inhibited MMP-2 expression, which is linked to tumor invasion.
  • Vimentin organization was altered in the presence of EGCG, suggesting a mechanism for reduced cell migration.

Takeaway

EGCG, a compound in green tea, helps stop cancer cells from moving around, which is important for stopping cancer spread.

Methodology

The study used 2D and 3D cell culture models to assess the effect of EGCG on cell migration and protein expression.

Limitations

The study primarily used in vitro models, which may not fully replicate in vivo conditions.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1465-9921-9-33

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication